Mostrant 1 a 20 de 158 resultats
DataTítolAutor(s)Tipus
2023Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.Vargas V; Akarca US; Alvares-da-Silva MR; Andreone P; Arrese M; Jones D; Germain JM; Levy C; Francque SM; Lawitz E; Mayo MJ; Shiffman ML; Swain MG; Valera JM; Villamil A; Shu J; Zein CO; Kowdley KV; Bowlus CL; Heneghan MA; Kruger FC; Addy C; Rafailovic D; Tadde B; Schattenberg JM; Corpechot C; Invernizzi P; Vierling JM; Dietrich J; Mazain S; Miller B; Article
2023Novel prognostic biomarkers in decompensated cirrhosisJuanola, A.; Ma, AT.; de Wit, K.; Gananandan, K.; Roux, O.; Zaccherini, G.; Jiménez, C.; Tonon, M.; Solé, C.; Villaseca, C.; Uschner, FE.; Graupera, I.; Pose, E.; Moreta, MJ.; Campion, D.; Beuers, U.; Mookerjee, RP.; Francoz, C.; Durand, F.; Vargas, V.; Piano, S.; Alonso, S.; Trebicka, J.; Laleman, W.; Asrani, SK.; Soriano, G.; Alessandria, C.; Serra-Burriel, M.; Morales-Ruiz, M.; Torres, F.; Allegretti, AS.; Krag, A.; Caraceni, P.; Watson, H.; Abraldes, JG.; Solà, E.; Kamath, PS.; Hernaez, R.; Ginès, P.; LiverHope Investigators Aban, M.; Andrade, R.; Angeli, P.; Avitabile, E.; Bassegoda, O.; Bernardi, M.; Carol, M.; Cervera, M.; Chiappa, MT.; Esnault, V.; Fabrellas, N.; Farrés, J.; Ferstl, P.; Gratacós-Ginès, J.; Joyera, M.; Korenjak, M.; Martínez, S.; Montagnese, S.; Napoleone, L. Nicolao, G.; Palacio, E.; Pavesi, M.; Pérez-Guasch, M.; Pich, J.; Rubio, AB.; Schulz, M.; Simon-Talero, M.; Vives, A.Article
2023Sympathetic nervous activation mitochondrial dysfunction and outcome in acutely decompensated cirrhosis the metabolomic prognostic models CLIF-C MET .Genesca J; Vargas V; Jimenez C; Sierra P; Diaz JM; Castelli FA; Domenicali M; Gu W; Papp M; Giovo I; Merli M; Putignano A; Uschner FE; Sanchez-Garrido C; Martin PI; Gustot T; Laleman W; Albillos A; Caraceni P; Saliba F; Zeuzem S; Wendon JA; Zaccherini G; Berg T; Bruns T; Banares R; Fernandez J; Bernardi M; Jalan R; Claria J; Moreau R; Arroyo V; de la Pena-Ramirez C; Fenaille F; Trautwein C; Zipprich A; Presa J; Angeli P; Junot C; Weiss E; Aguilar F; Lozano JJ; Alessandria C; Piano S; Gerbes AL; Jansen C; Mookerjee R; Gambino CG; Trebicka J; Article
2022Final Safety and Efficacy Results from a 106 Real-World Patients Registry with an Ascites-Mobilizing Pump.Vargas V; Herber A; Spahr L; Banz V; Babatz J; Engelmann C; Trepte C; De Gottardi A; Berg T; Zeuzem S; McPherson S; Lammert F; Capel J; Stirnimann G; Storni F; Geier A; Article
2022Clinical, histological and molecular profiling of different stages of alcohol-related liver diseaseVentura-Cots, M; Argemi, J; Jones, PD; Lackner, C; El Hag, M; Abraldes, JG; Clemente, A; Ravi, S; Alves, A; Alboraie, M; Altamirano, J; Barace, S; Bosques, F; Brown, R; Caballeria, J; Cabezas, J; Carvalhana, S; Cortez-Pinto, H; Costa, A; Degre, D; Fernandez-Carillo, C; Ganne-Carrie, N; Garcia-Tsao, G; Genesca, J; Koskinas, J; Lanthier, N; Louvet, A; Lozano, JJ; Lucey, MR; Masson, S; Mathurin, P; Mendez-Sanchez, N; Miquel, R; Moreno, C; Mounajjed, T; Odena, G; Kim, W; Sancho-Bru, P; Sands, RW; Verset, L; Schnabl, B; Sempoux, C; Shah, VJ; Shawcross, DL; Stauber, RE; Straub, BK; Verna, E; Tiniakos, D; Trepo, E; Vargas, V; Woosley, JT; Ziol, M; Mueller, S; Starkel, P; Bataller, R; Alvarado, E; Szafranska, J; Villanueva, CArticle
2022Value of pilot studies in alcohol-associated hepatitis.Jimenez C; Vargas V; Bataller R; Ventura-Cots M; Article
2022Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated CirrhosisPose, E.; Solà, E.; Lozano, JJ.; Juanola, A.; Sidorova, J.; Zaccherini, G.; de Wit, K.; Uschner, F.; Tonon, M.; Kazankov, K.; Jiménez, C.; Campion, D.; Napoleone, L.; Ma, AT.; Carol, M.; Morales-Ruiz, M.; Alessandria, C.; Beuers, U.; Caraceni, P.; Francoz, C.; Durand, F.; Mookerjee, RP.; Trebicka, J.; Vargas, V.; Piano, S.; Watson, H.; Abraldes, JG.; Kamath, PS.; Davis, MM.; Ginès, P.; investigators of the LIVERHOPE Consortium.Article
2022Correction to The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis A Global Study.Vargas V; Altamirano J; Abraldes JG; Thursz MR; Chavez-Araujo R; Kamath PS; Duarte-Rojo A; Zamarripa F; Restrepo-Gutierrez J; Garcia-Tsao G; Brown RS Jr; Fernandez-Carrillo C; Forrest E; Bataller R; Atkinson SR; Singal AK; Jager M; Rautou PE; Torre A; Lucey MR; Arab JP; Argemi J; Alvarado-Tapias E; Cruz-Lemini M; Shah VH; Rincon D; Morales-Arraez D; Ventura-Cots M; Sarin SK; Kim W; Higuera-de la Tijera; Charles EA; Mathurin P; Louvet A; Gonzalez JA; Verna EC; Clemente A; Allison M; Article
2022Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in a Real-World Cohort of Patients With Alcoholic HepatitisParker, R; Cabezas, J; Altamirano, J; Arab, JP; Ventura-Cots, M; Sinha, A; Dhanda, A; Arrese, M; McCune, CA; Rowe, IA; Schnabl, B; Mathurin, P; Shawcross, D; Abraldes, JG; Lucey, MR; Garcia-Tsao, G; Verna, E; Brown, RS; Bosques-Padilla, F; Vargas, V; Louvet, A; Holt, AP; Bataller, RArticle
2022The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global StudyMorales-Arráez D.; Ventura-Cots M.; Altamirano J.; Abraldes J.G.; Thursz M.R.; Atkinson S.R.; Sarin S.K.; Kim W.; Chavez-Araujo R.; Higuera-De La Tijera M.F.; Singal A.K.; Shah V.H.; Kamath P.S.; Duarte-Rojo A.; Charles E.A.; Vargas V.; Jager M.; Rautou P.E.; Rincon D.; Zamarripa F.; Restrepo-Gutiérrez J.C.; Torre A.; Lucey M.R.; Arab J.P.; Mathurin P.; Louvet A.; García-Tsao G.; González J.A.; Verna E.C.; Brown R.S.; Argemi J.; Fernández-Carillo C.; Clemente A.; Alvarado-Tapias E.; Forrest E.; Allison M.; Bataller R.; Cruz-Lemini M.Article
2022Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH)Genesca Ferrer, Juan;Jiménez, Cesar;Ventura-Cots, Meritxell;Sala Llinas, Margarita;Calafat, Margalida;Garcia-Retortillo, M.;Cirera, Isabel;Cañete Hidalgo, Nuria;Soriano, German;Poca Sans, Maria;Simon-Talero, Macarena;Altamirano, José;Lucey, Michael;Garcia-Tsao, G.;Brown, R. S.;Schwabe, R. F.;Verna, Elizabeth;Schnabl, Bernd;Bosques, Francisco;Mathurin, Philippe;Louvet, Alexandre;Shawcross, Debbie;Abraldes, Juan G.;Bataller, Ramon;Vargas, V.Article
2022Risk of infections in patients with NAFLD and Type 2 Diabetes under treatment with SGLT2 inhibitors and relationship with liver outcomes :Salcedo Allende, Maria Teresa;Genesca Ferrer, Juan;Bañares, Juan;Manzano-Nuñez, Ramiro;Prió, Alba;Rivera-Esteban, Jesús;Camps-Relats, Laura;Villarejo, Ana;Ruiz-Ortega, Lourdes;Pons, Mònica;Ciudin, Andreea;Vargas, Víctor;Pericàs, Juan M.Article
2022Non-Invasive Tests of Liver Fibrosis Help in Predicting the Development of Hepatocellular Carcinoma among Patients with NAFLD.Banares J; Bermudez M; Castells L; Pons M; Rivera-Esteban J; Vargas V; Salcedo-Allende MT; Pericas JM; Manzano R; Augustin S; Minguez B; Article
2021Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide studyArab, JP; Diaz, LA; Baeza, N; Idalsoaga, F; Fuentes-Lopez, E; Arnold, J; Ramirez, CA; Morales-Arraez, D; Ventura-Cots, M; Alvarado-Tapias, E; Zhang, W; Clark, V; Simonetto, D; Ahn, JC; Buryska, S; Mehta, TI; Stefanescu, H; Horhat, A; Bumbu, A; Dunn, W; Attar, B; Agrawal, R; Haque, ZS; Majeed, M; Cabezas, J; Garcia-Carrera, I; Parker, R; Sarin, SK; Maiwall, R; Jalal, PK; Abdulsada, S; Higuera-de la Tijera, MF; Kulkarni, AV; Rao, PN; Salazar, PG; Skladany, L; Bystrianska, N; Prado, V; Clemente-Sanchez, A; Rincon, D; Haider, T; Chacko, KR; Cairo, F; Coelho, MD; Romero, GA; Pollarsky, FD; Restrepo, JC; Castro-Sanchez, S; Toro, LG; Yaquich, P; Mendizabal, M; Garrido, ML; Narvaez, A; Bessone, F; Marcelo, JS; Piombino, D; Dirchwolf, M; Arancibia, JP; Altamirano, J; Kim, W; Araujo, RC; Rojo, AD; Vargas, V; Rautou, PE; Issoufaly, T; Zamarripa, F; Torre, A; Lucey, MR; Mathurin, P; Louvet, A; Garcia-Tsao, G; Gonzalez, JA; Verna, E; Brown, RS; Roblero, JP; Abraldes, JG; Arrese, M; Shah, VH; Kamath, PS; Singal, AK; Bataller, R; Cuyas, B; Poca, M; Soriano, GArticle
2021Obeticholic Acid and Fibrates in Primary Biliary Cholangitis Comparative Effects in a Multicentric Observational Study.Reig, A; Alvarez-Navascues, C; Vergara, M; Gomez-Dominguez, E; Gallego-Moya, A; Perez-Medrano, IM; Fabrega, E; Hernandez-Guerra, M; Berenguer, M; Estevez, P; Arencibia, A; Morillas, RM; Horta, D; Albillos, A; Casado, M; De la Cruz, G; Fernandez-Bonilla, E; Molina, E; Hijona, L; Diago, M; Fernandez-Rodriguez, CM; Gonzalez-Santiago, JM; Sala, M; Gomez-Camarero, J; Romero-Gomez, M; Suarez, F; Vargas, V; Ferre-Aracil, C; Andrade, RJ; Chahri, N; Pares, AArticle
2021The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With Alcohol-Associated HepatitisVentura-Cots M; Vargas V; Altamirano J; Eickhoff J; Brown RS Jr; Schnabl B; Musto JA; Shawcross D; Mathurin P; Garcia-Tsao G; Louvet A; Lucey MR; Abraldes JG; Bosques-Padilla F; Verna EC; Caballeria J; Bataller R; Article
2021The use of Rifaximin in Patients with Cirrhosis.Caraceni, P.; Vargas, V.; Solà, E.; Alessandria, C.; de Wit, K.; Trebicka, J.; Angeli, P.; Mookerjee, R.P.; Durand, F.; Pose, E.; Krag, A.; Bajaj, J.S.; Beuers, U.; Ginès, P.; Liverhope ConsortiumArticle
2021A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation.Vargas V; Michel S; Vainilovich Y; Clerget-Chossat N; Sokal EM; Gustot T; Lasser LL; Stoykov I; Laterre PF; Najimi M; Nevens F; Haralampiev LE; Lyubomirova D; Albillos A; Gordillo N; Barthel V; Article
2021Does Routine Abdominal Drain Tip Culture Anticipate Post-Operative Infection in Liver TransplantationLos-Arcos I; Castells L; Vargas V; Lung M; Nuvials X; Perez-Cameo C; Hidalgo E; Gomez-Gavara C; Len O; Article
2021Frailty in outpatients with cirrhosis a prospective observational study.Roman, E; Parramon, M; Flavia, M; Gely, C; Poca, M; Gallego, A; Hernandez, E; Nieto, JC; Urgell, E; Alvarado-Tapias, E; Vidal, S; Ferrero-Gregori, A; Vargas, V; Guarner, C; Soriano, G; Santesmases, RArticle